Hope After Salvage Therapy Fails: Novel Agents for Relapsed/Refractory Hodgkin Lymphoma... [including commentary by John W. Sweetenham].
- Published in:
- Oncology (08909091), 2019, v. 33, n. 5, p. 192
- By:
- Publication type:
- Article
Works matching IS 08909091 AND DT 2019 AND VI 33 AND IP 5
Results: 7
1
2
State of Cancer Research Around the Globe.
- Published in:
- Oncology (08909091), 2019, v. 33, n. 5, p. 181
- By:
- Publication type:
- Article
3
The Role of Primary Tumor Treatment and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer.
- Published in:
- Oncology (08909091), 2019, v. 33, n. 5, p. 187
- By:
- Publication type:
- Article
4
FDA Approves Two New Indications and Dosage Form for Pembrolizumab.
- Published in:
- Oncology (08909091), 2019, v. 33, n. 5, p. 186
- By:
- Publication type:
- Article
5
Evaluating Immunotherapy in Nonmetastatic Colorectal Cancer... [including commentary by Ronit Yarden].
- Published in:
- Oncology (08909091), 2019, v. 33, n. 5, p. 178
- By:
- Publication type:
- Article
6
Non-Small-Cell Lung Cancer After Mantle Radiation: A Case Report and Brief Review.
- Published in:
- Oncology (08909091), 2019, v. 33, n. 5, p. 174
- By:
- Publication type:
- Article
7
When Surgery Is Not an Option in Renal Cell Carcinoma: The Evolving Role of Stereotactic Body Radiation Therapy.
- Published in:
- Oncology (08909091), 2019, v. 33, n. 5, p. 167
- By:
- Publication type:
- Article